Journal of Gastric Cancer

  • 제12권3호
  • /
  • Pages.164-172
  • /
  • 2012
  • /
  • 2093-582X(pISSN)
  • /
  • 2093-5641(eISSN)
대한위암학회 (The Korean Gastric Cancer Association)
권호 표지
DOI QR코드

DOI QR Code

Tumor Size as a Prognostic Factor in Gastric Cancer Patient

  • Im, Won Jin (Department of Surgery, Hanyang University College of Medicine) ;
  • Kim, Min Gyu (Department of Surgery, Hanyang University College of Medicine) ;
  • Ha, Tae Kyung (Department of Surgery, Hanyang University College of Medicine) ;
  • Kwon, Sung Joon (Department of Surgery, Hanyang University College of Medicine)
  • 투고 : 2012.06.08
  • 심사 : 2012.08.20
  • 발행 : 2012.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The purpose of this study is to investigate the prognostic significance of tumor size for 5-year survival rate in patients with gastric cancer. Materials and Methods: A total of 1,697 patients with gastric cancer, who underwent potentially curative gastrectomy, were evaluated. Patients were divided into 4 groups as follows, according to the median size of early and advanced gastric cancer, respectively: small early gastric cancer (tumor size ${\leq}3$ cm), large early gastric cancer (tumor size >3 cm), small advanced gastric cancer (tumor size ${\leq}$ 6 cm), and large advanced gastric cancer (tumor size >6 cm). The prognostic value of tumor size for 5-year survival rate was investigated. Results: In a univariate analysis, tumor size is a significant prognostic factor in advanced gastric cancer, but not in early gastric cancer. Multivariate analysis showed that tumor size is an independent prognostic factor for 5-year survival rate in advanced gastric cancer (P=0.003, hazard ratio=1.372, 95% confidence interval=1.115~1.690). When advanced gastric cancer is subdivided into 2 groups, according to serosa invasion: Group 1; serosa negative (T2 and T3, 7th AJCC), and Group 2; serosa positive (T4a and T4b, 7th AJCC), tumor size is an independent prognostic factor in Group 1 (P=0.011, hazard ratio=1.810, 95% confidence interval=1.149~2.852) and in Group 2 (P=0.033, hazard ratio=1.288, 95% confidence interval=1.020~1.627), respectively. Conclusions: Tumor size is an independent prognostic factor in advanced gastric cancer irrespective of the serosa invasion, but not in early gastric cancer.

키워드

참고문헌

  1. Cheung LY, Delcore R. Gastric cancer. In: Townsend CM, ed. Sabiston Textbook of Surgery. 16th ed. Philadelphia: W.B. Saunders; 2001:855-865.
  2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, WardE, et al; American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29. https://doi.org/10.3322/canjclin.54.1.8
  3. Kim W, Park CH, Park SM, Park WB, Lim KW, Kim SN. Prognostic significance of lymphatic and perineural invasions in patients with gastric cancer who have no lymph node and serosal involvement. J Korean Gastric Cancer Assoc 2001;1:77-82.
  4. Huh H, Hyung WJ, Chen J, Choi SH, Noh SH. Implication of lymphatic or blood vessel invasion in early gastric cancer. J Korean Surg Soc 2003;64:134-139.
  5. Kim JJ, Song KY, Hur H, Hur JI, Park SM, Park CH. Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol 2009;35:409-414. https://doi.org/10.1016/j.ejso.2008.05.004
  6. Suh KW, Kim CB, Kim MW, Chi HS, Cho CH, Kim BR, et al. A clinical study of 2789 gastric cancers. J Korean Surg Soc 1991;41:148-158.
  7. Park CH, Kim DG, Jung SS, Yoo SJ, Lee MD, Kim SK, et al. Clinical analysis of gastric adenocarcinoma experienced during recent 10 years and follow up results. J Korean Surg Soc 1992;42:787-798.
  8. Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y, et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992;70:1030-1037. https://doi.org/10.1002/1097-0142(19920901)70:5<1030::AID-CNCR2820700504>3.0.CO;2-C
  9. Sobin LH, Wittekind C, eds. International Union against Cancer. TNM Classification of Malignant Tumours. 5th ed. New York: Wiley-Liss, 1997.
  10. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010;17:3077-3079. https://doi.org/10.1245/s10434-010-1362-z
  11. Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi K. Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol 1997;4:137-140. https://doi.org/10.1007/BF02303796
  12. Giuliani A, Caporale A, Di Bari M, Demoro M, Gozzo P, Corona M, et al. Maximum gastric cancer diameter as a prognostic indicator: univariate and multivariate analysis. J Exp Clin Cancer Res 2003;22:531-538.
  13. Li C, Oh SJ, Kim S, Hyung WJ, Yan M, Zhu ZG, et al. Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size. J Gastrointest Surg 2009;13:881-885. https://doi.org/10.1007/s11605-009-0800-3
  14. Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Oro S, et al. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg 2006;192:296-300. https://doi.org/10.1016/j.amjsurg.2006.03.004
  15. Liu X, Xu Y, Long Z, Zhu H, Wang Y. Prognostic significance of tumor size in T3 gastric cancer. Ann Surg Oncol 2009;16:1875-1882. https://doi.org/10.1245/s10434-009-0449-x
  16. Maehara Y, Orita H, Okuyama T, Moriguchi S, Tsujitani S, Korenaga D, et al. Predictors of lymph node metastasis in early gastric cancer. Br J Surg 1992;79:245-247. https://doi.org/10.1002/bjs.1800790320
  17. Tsujitani S, Oka S, Saito H, Kondo A, Ikeguchi M, Maeta M, et al. Less invasive surgery for early gastric cancer based on the low probability of lymph node metastasis. Surgery 1999;125:148-154. https://doi.org/10.1016/S0039-6060(99)70258-8
  18. Yamamura Y, Nakajima T, Ohta K, Nashimoto A, Arai K, Hiratsuka M, et al. Determining prognostic factors for gastric cancer using the regression tree method. Gastric Cancer 2002;5:201-207. https://doi.org/10.1007/s101200200035
  19. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-425. https://doi.org/10.1007/BF01655804
  20. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, et al; Italian Research Group for Gastric Cancer. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 2003;90:1113-1119. https://doi.org/10.1002/bjs.4164
  21. Yokota T, Ishiyama S, Saito T, Teshima S, Yamada Y, Iwamoto K, et al. Is tumor size a prognostic indicator for gastric carcinoma? Anticancer Res 2002;22:3673-3677.
  22. Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S. Multivariate prognostic study on large gastric cancer. J Surg Oncol 2007;96:14-18. https://doi.org/10.1002/jso.20631
  23. Yasuda K, Shiraishi N, Adachi Y, Inomata M, Sato K, Kitano S. Risk factors for complications following resection of large gastric cancer. Br J Surg 2001;88:873-877. https://doi.org/10.1046/j.0007-1323.2001.01782.x
  24. Jun KH, Jung H, Baek JM, Chin HM, Park WB. Does tumor size have an impact on gastric cancer? A single institute experience. Langenbecks Arch Surg 2009;394:631-635. https://doi.org/10.1007/s00423-008-0417-0

피인용 문헌

  1. Survival Analysis of Gastric Cancer Patients with Incomplete Data vol.14, pp.4, 2012, https://doi.org/10.5230/jgc.2014.14.4.259
  2. Macroscopic Serosal Classification as a Prognostic Index in Radically Resected Stage pT3-pT4b Gastric Cancer vol.23, pp.1, 2012, https://doi.org/10.1245/s10434-015-4656-3
  3. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy vol.10, pp.None, 2012, https://doi.org/10.2147/dddt.s88743
  4. Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy vol.5, pp.1, 2012, https://doi.org/10.1186/s40064-016-2535-4
  5. Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis vol.2017, pp.None, 2012, https://doi.org/10.1155/2017/1320241
  6. Improvement of T stage precision by integration of surgical and pathological staging in radically resected stage pT3-pT4b gastric cancer vol.8, pp.28, 2012, https://doi.org/10.18632/oncotarget.14828
  7. Promoter hypermethylation of RAR-β tumor suppressor gene in gastric carcinoma: Association with histological type and clinical outcomes vol.20, pp.1, 2017, https://doi.org/10.3233/cbm-160331
  8. Cáncer gástrico incipiente gigante: reporte de un caso vol.69, pp.5, 2012, https://doi.org/10.1016/j.rchic.2016.11.003
  9. Large tumor size is a poor prognostic factor of gastric cancer with signet ring cell : Results from the surveillance, epidemiology, and end results database vol.98, pp.40, 2012, https://doi.org/10.1097/md.0000000000017367
  10. Natural history of early gastric cancer: series of 21 cases vol.7, pp.1, 2012, https://doi.org/10.1055/a-0746-3329
  11. The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment vol.10, pp.1, 2012, https://doi.org/10.1093/advances/nmy090
  12. Clinicopathological Evaluation of Gastric Signet Ring Cell Carcinoma: Our Experience vol.10, pp.2, 2012, https://doi.org/10.5005/jp-journals-10018-1325
  13. Application of gene expression programming and sensitivity analyses in analyzing effective parameters in gastric cancer tumor size and location vol.24, pp.13, 2012, https://doi.org/10.1007/s00500-019-04507-0
  14. Radiologic serosal invasion sign as a new criterion of T4a gastric cancer on computed tomography: diagnostic performance and prognostic significance in patients with advanced gastric cancer vol.45, pp.10, 2012, https://doi.org/10.1007/s00261-019-02156-3